Final SPARTAN data show OS benefit
- PMID: 32948853
- DOI: 10.1038/s41585-020-00381-w
Final SPARTAN data show OS benefit
Comment on
-
Apalutamide and Overall Survival in Prostate Cancer.Eur Urol. 2021 Jan;79(1):150-158. doi: 10.1016/j.eururo.2020.08.011. Epub 2020 Sep 6. Eur Urol. 2021. PMID: 32907777 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources